drugset / Trial / NCT00588185

[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

NCT00588185

Recruiting 300 enrolled Memorial Sloan Kettering Cancer Center
NaSingle-groupOpen-labelDiagnostic

Summary

This study will use PET scans, which is a type of x-ray test that uses a radiotracer, to see whether these scans may be better able to find places in the body where your prostate cancer may have spread.

Timeline

Start
2003-02
Primary completion
2027-02
Completion
2027-02

Drugs

EvaluationDrugModalityDoseRoute
Subject [18F] DIHYDRO-TESTOSTERONE Diagnostic / imaging agent
Subject [18F]fluoro-2-deoxy-D-glucose Diagnostic / imaging agent

Indications